Repligen | RGEN - 应收帐款人



金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 606.78M
销售成本
USD 94.09M
流动资产
USD 1.2B
流动负债
USD 132.66M
债务
USD 690.94M
EBIT
USD 21.13M
EBITDA
USD 43.77M
员工
1.78K
EPS每股收益
USD 0.54
股本和储备
USD 2.11B
销售毛利
USD 110.04M
债务利息支出
USD 5.66M
利息收入
USD 7.31M
贷款资金
USD 551.05M
市值
USD 9.21B
净收入
USD 5.01M
营业费用
USD 183M
营业利润
USD 21.13M
普通股股本
USD 56.43M
PE价格收益
105.09
税前利润
USD 14.15M
销售收入
USD 204M
销售和管理费用
USD 76.62M
股票
USD 186.6M
贸易债权人
USD 33.23M
应收帐款人
USD 157.71M


应收帐款人 更改 日
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.15B 23.28M 2026-06
Bio Techne USD 214.56M 29.95M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Bruker USD 545.9M 3.2M 2026-06
Charles River Laboratories USD 711.76M 11.5M 2026-06
Danaher USD 4.96B 205M 2026-06
Dentsply International USD 620M 2M 2026-06
General Electric Aerospace USD 22.36B 186M 2026-06
Henry Schein USD 1.76B 44M 2026-06
Illumina USD 764M 26M 2026-06
IQVIA Holdings USD 3.39B 12M 2026-06
Mettler Toledo International USD 731.48M 23.27M 2026-06
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pfizer USD 16.19B 19M 2026-06
Repligen USD 157.71M 6.16M 2026-06
Revvity USD 709.18M 17.79M 2026-06
Standard Biotools USD 41.64M 28.21M 2026-03
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Waters USD 1.99B 228M 2026-06
West Pharmaceutical Services USD 712M 26.4M 2026-06